ArticleJCEM case reports2026
Betel leaf (paan) chewing: an unusual cause of refractory hypothyroidism in levothyroxine-treated patient.
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The habit of chewing betel leaf, or "paan", is prevalent in different parts of India. Betel leaves, areca nut, and lime are common ingredients of paan. Preclinical studies have demonstrated that betel leaf and areca nut affect thyroid function. Lime, due to its high calcium content, adsorbs levothyroxine (LT4) tablets. It is worthwhile to consider paan consumption as a possible etiology of "refractory hypothyroidism" in individuals being treated with a standard LT4 replacement dose in India. Chronic paan chewing causes reddish discoloration of the tongue. Encountering such a finding on examination in a patient with persistently elevated thyroid-stimulating hormone (TSH) should prompt the treating physician to meticulously inquire about dietary patterns and other habits. This is important when there is a consistent denial of noncompliance and an absence of clinical suggestions of malabsorptive and systemic diseases. We describe here a patient with primary autoimmune hypothyroidism with persistently elevated TSH, despite being on an unusually high dose of LT4, due to his habit of paan chewing. The red- colored tongue provided us a clue about the habit. TSH normalization was achieved with the standard replacement dose of LT4 following the cessation of paan consumption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.